During the past decade, IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima" are "Bladder Cancer" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Cholangiocellular Carcinoma" (1 trials) and "Classical Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima" in a lesser frequency.

Most popular intervention types in "IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima" are "Drug" (13 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Bevacizumab" (4 trials), "Carboplatin" (2 trials), "Cetuximab" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".